Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial.
By K. Kuck, A. Schaumann, L. Eckardt, S. Willems, R. Ventura, E. Delacrétaz, H. Pitschner, J. Kautzner, B. Schumacher, P. Hansen. The Lancet, 2010
710 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine
View Paper: https://www.semanticscholar.org/paper/c07f07f763687d5eeaa20d4b4571c42365913650
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
Citations in the corpus
- 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the preventionof sudden cardiac death (2015, positive): “Data from two prospective randomized multicentre trials on outcome in patients with ischaemic heart disease demonstrated that catheter ablation for VT decreases the likelihood of subsequent ICD shocks and prevents recurrent episodes of VT.(187,188) Moreover, catheter ablation is often used to contro”